ICD-10 code G72. 0 for Drug-induced myopathy is a medical classification as listed by WHO under the range - Diseases of the nervous system .
ICD-10 Code for Myopathy, unspecified- G72. 9- Codify by AAPC.
A drug-induced, or toxic, myopathy is defined as the acute or subacute manifestation of myopathic symptoms such as muscle weakness, myalgia, creatine kinase elevation, or myoglobinuria that can occur in patients without muscle disease when they are exposed to certain drugs.
6X5- when a patient has know intolerance to statin medication.
Definition. The myopathies are neuromuscular disorders in which the primary symptom is muscle weakness due to dysfunction of muscle fiber. Other symptoms of myopathy can include include muscle cramps, stiffness, and spasm.
Other and unspecified myopathies Impairment of health or a condition of abnormal functioning of the muscle. Your muscles help you move and help your body work. Different types of muscles have different jobs. There are many problems that can affect muscles. Muscle disorders can cause weakness, pain or even paralysis.
Statin-induced myopathy brings on muscle-related symptoms that didn't exist prior to when you started taking a statin. Symptoms tend to start soon after you begin statin therapy. The disorder may include any or all of the following symptoms: muscle pain. muscle weakness.
Different Types of MyopathiesMuscular Dystrophies. Muscular dystrophies are characterized by a lack of protein called dystrophin. ... Congenital Myopathy. ... Metabolic Myopathy. ... Mitochondrial Myopathy. ... Channelopathies. ... Myotonia Congenita. ... Inflammatory Myopathy. ... Endocrine Myopathy.More items...
Many drugs can induce vacuolar myopathy (colchicine, chloroquine, amiodarone, cyclosporin, drugs causing hypokalaemia and lipid-lowering agents), some others cause a mitochondrial myopathy (zidovudine) or a necrotizing myopathy as seen with vincristine.
As the name suggests, statin intolerance occurs when a patient is unable to continue to use a statin, either because of the development of a side effect or because of evidence on a blood test that certain markers of liver function or muscle function (creatine kinase) are sufficiently abnormal to cause concern. 2.
Myalgia is a potential adverse effect of statin treatment Myalgia, with or without muscle weakness, is the most common adverse effect associated with statin use, and is reported to occur in up to 10% of people prescribed statins.
ICD-10 code M79. 1 for Myalgia is a medical classification as listed by WHO under the range - Soft tissue disorders .
The 2022 edition of ICD-10-CM G72.2 became effective on October 1, 2021.
In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere.". Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code.
The 2022 edition of ICD-10-CM G73.7 became effective on October 1, 2021.
In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere.". Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code.
T46- Poisoning by , adverse effect of and underdosing of agents primarily affecting the cardiovascular system
Use secondary code (s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code. Type 1 Excludes.